Miller Care Group
Also listed as IndyTransitions
Miller Care Group is an addiction treatment facility at 3850 Shore Drive, Indianapolis, Indiana 46254, in Marion County. It reports detox, intensive outpatient (iop), outpatient, telehealth to SAMHSA.
Facility details
- Phone
- (317) 429-0061 ext. 101
- Address
- 3850 Shore Drive, Suite 315, Indianapolis, IN 46254
- County
- Marion County
- Website
- www.millercaregroup.com
Level of care
Medication for addiction treatment
Licensing and accreditation
- Drug Enforcement Agency (DEA)
Payment accepted
Specialised programs
Ages accepted
Sex accepted
Everything Miller Care Group reports to SAMHSA
113 service codes across 26 categories. Terms SAMHSA defines link to the glossary; the rest are federal labels SAMHSA publishes without a definition.
Age Groups Accepted
Ancillary Services
- Case management service
- Domestic violence services, including family or partner
- Early intervention for HIV
- Integrated primary care services
- Mental health services
- Suicide prevention services
- Social skills development
- Transportation assistance
Assessment/Pre-treatment
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Interim services for clients
- Complete medical history/physical exam
- Outreach to persons in the community
- Professional interventionist/educational consultant
- Screening for mental disorders
- Screening for substance use
- Screening for tobacco use
Type of Alcohol Use Disorder Treatment
- This facility administers/prescribes medication for alcohol use disorder
Detoxification (medical withdrawal) Services
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Cocaine Detoxification
- Medication routinely used during detoxification
- Methamphetamines detoxification
- Opioids detoxification
Education and Counseling Services
- Family counseling
- Group counseling
- HIV or AIDS education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Marital/couples counseling
- Substance use disorder education
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
Facility Operation (e.g., Private, Public)
Facility Vaping Policy
- Vaping permitted in designated area
License/Certification/Accreditation
- Drug Enforcement Agency (DEA)
Opioid Medications used in Treatment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
External Opioid Medications Source
- No formal relationship with prescribing entity
Type of Opioid Treatment
- Buprenorphine maintenance
- Buprenorphine detoxification
- Lofexidine or Clonidine detoxification
- Accepts clients using MAT but prescribed elsewhere
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Prescribes naltrexone
Other Services
- Treatment for gambling disorder
- Treatment for other addiction disorder
Payment/Insurance/Funding Accepted
- Cash or self-payment
- Medicare
- Medicaid
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Federal military insurance (e.g., TRICARE)
Pharmacotherapies
- Acamprosate (Campral®)
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Clonidine
- Disulfiram
- Lofexidine
- Medications for Hepatitis C treatment
- Medications for HIV treatment
- Medication for mental disorders
- Medications for pre-exposure to prophylaxis
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
Payment Assistance Available
Recovery Support Services
- Housing services
- Mentoring/peer support
Testing
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- Testing for Hepatitis C (HCV)
- HIV testing
- Metabolic syndrome monitoring
- STD testing
- TB screening
Service Setting
- Intensive outpatient treatment
- Outpatient detoxification
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Regular outpatient treatment
Special Programs/Groups Offered
- Clients with co-occurring pain and substance use disorders
- Clients with co-occurring mental and substance use disorders
External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity
- No formal relationship with prescribing entity
Facility Smoking Policy
Treatment Approaches
Type of Care
Transitional Services
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
- Outcome follow-up after discharge
Before you go: availability, cost, and accepted insurance change often. Call the facility to confirm. If something on this page is wrong, tell us and we will correct it.
Source: SAMHSA FindTreatment.gov facility listing (Indiana), parsed 2026-08-19.